Predicting survival after ECMO for refractory cardiogenic shock: the survival after veno-arterial-ECMO (SAVE)-score

Schmidt, Matthieu; Burrell, Aidan; Roberts, Lloyd A.; Bailey, Michael; Sheldrake, Jayne; Rycus, Peter; Hodgson, Carol; Scheinkestel, Carlos; Cooper, Jamie; Thiagarajan, Ravi R.; Brodie, Daniel; Pellegrino, Vincent; Pilcher, David

doi:10.1093/eurheartj/ehv194

Cited by 728 publications

(696 citation statements)

References 39 publications

Supporting

Mentioning

644

Contrasting

Unclassified

Order By: Relevance

“…Typowe zastosowanie takich urządzeń jest ograniczone do dni lub tygodni. Skala SAVE (The Survival After Veno-arterial ECMO) może być pomocna w przewidywaniu przeżycia u osób leczonych za pomocą ECMO z powodu opornego wstrząsu kardiogennego (kalkulator on-line dostępny pod adresem: http://www.save-score.com) [594].…”

Section: Mechaniczne Wspomaganie Krążenia W Ostrej Niewydolności Sercaunclassified

2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

Ponikowski

Voors

Anker³

et al. 2016

Kardiol Pol

459

446

View full text Add to dashboard Cite

Section: Mechaniczne Wspomaganie Krążenia W Ostrej Niewydolności Sercaunclassified

2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

Ponikowski

Voors

Anker³

et al. 2016

Kardiol Pol

459

446

View full text Add to dashboard Cite

“…The first possibility is the application at the moment of triage of different scores validated for MCS implantation for cardiogenic shock, but burdened by a low proportion of ECPR in the derivation or validation cohort (16)(17)(18). We strongly believe that the application of scores outside the original setting is not the right choice to decide the fate of a cardiac arrest patient.…”

Section: Federico Pappalardo 1 Andrea Montiscimentioning

confidence: 99%

What is extracorporeal cardiopulmonary resuscitation?

Pappalardo¹,

Montisci²

2017

J. Thorac. Dis.

View full text Add to dashboard Cite

“…VA-ECMO may thus be life saving in specific patient population especially with severe cardiac dysfunction [9]. The economic burden and complications of ECMO especially related to bleeding in vital organs or ischemic damage to limbs should be explained and taken care of.…”

Section: Citationmentioning

confidence: 99%

VA-ECMO in Landouzy Sepsis or Tubercular Septic Shock

2017

JACCOA

View full text Add to dashboard Cite

Landouzy-Sepsis (Sepsis tuberculosa acutissima) is a rare presentation of disseminated tuberculosis as shock and multi-organ failure. The condition if not treated promptly causes rapid death in an immunocompromised patient. We report one such case with refractory shock, ARDS, renal failure and liver dysfunction treated with peri-arrest VA-ECMO at our centre. The use of VA-ECMO have been explained in several scenarios for maintaining oxygenation and perfusion in cases of irreversible cardio-respiratory failure. In a developing country like ours, cost of initiating ECMO support has to be contemplated. We were successful in convincing the family to consent for the procedure and we initiated VA-ECMO on this patient after proper counseling of the family regarding possible outcome.

show abstract

Predicting survival after ECMO for refractory cardiogenic shock: the survival after veno-arterial-ECMO (SAVE)-score

Abstract: The SAVE-score may be a tool to predict survival for patients receiving ECMO for refractory cardiogenic shock (www.save-score.com).

Cited by 728 publications

References 39 publications

2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

What is extracorporeal cardiopulmonary resuscitation?

VA-ECMO in Landouzy Sepsis or Tubercular Septic Shock

Contact Info

Product

Resources

About